Health effects of ultraviolet irradiation in asthmatic children's homes

Jonathan A Bernstein1, R Carter Bobbitt, Linda Levin

  • 1Department of Internal Medicine, Division of Immunology, Allergy Section, Cincinnati, Ohio, USA. jonathan.Bernstein@uc.edu

Insights

Central UV irradiation improved peak expiratory flow rate variability and reduced asthma symptoms in children with mold allergies. Further research is needed to confirm these health benefits for allergic asthma management.

Area of Science:

  • Environmental Health
  • Pediatric Allergy
  • Respiratory Medicine

Background:

  • Mold sensitization is a common trigger for asthma in children.
  • Indoor air quality significantly impacts allergic asthma symptoms and severity.
  • Current interventions focus on allergen avoidance and medication, with a need for novel environmental strategies.

Purpose of the Study:

  • To evaluate the health benefits of centrally installed ultraviolet (UV) irradiation units in mold-sensitized asthmatic children.
  • To assess the impact of UV irradiation on clinical outcomes and indoor environmental parameters.

Main Methods:

  • A 28-week double-blinded placebo-controlled cross-over trial involving 19 mold-sensitized asthmatic children (ages 5-17).
  • Clinical outcomes included peak expiratory flow rates (PEFR), symptom scores, quality-of-life, and medication use.
  • Environmental monitoring assessed temperature, humidity, dew point, and airborne mold/bacterial counts.

Main Results:

  • A statistically significant improvement in PEFR variability was observed with UV irradiation (p < 0.05).
  • UV treatment led to significant reductions in asthma symptom scores and medication use during the first treatment period (p < 0.05).
  • No significant differences were found for other clinical or environmental outcomes between UV and placebo units.

Conclusions:

  • Central UV irradiation shows potential in reducing airway hyperresponsiveness (PEFR variability) and certain clinical symptoms in asthmatic children.
  • UV irradiation may be a viable indoor environmental intervention for allergic asthma.
  • Larger, controlled longitudinal studies are required to validate these findings and confirm clinical health effects.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...